TY  - JOUR

T1  - Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer.

JO  - Breast

PY  - 2005/10/01

AU  - El-Helw L

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1016/j.breast.2004.12.005

VL  - 14

IS  - 5

SP  - 368

EP  - 374

Y2  - 2025/10/10

ER  -